Alternations of Intestinal Microbiota and Health Impact in CKD
NCT ID: NCT03794401
Last Updated: 2022-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
750 participants
OBSERVATIONAL
2019-04-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)
NCT03010696
Chronic Kidney Disease at Northeast Taiwan: Biomarker and Multidisciplinary Care
NCT04300387
Population-based Chronic Kidney Disease Cohort at Northern Taiwan
NCT03004898
Multi-omics Analysis of Chronic Kidney Disease
NCT05543291
The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care
NCT03649516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with liver cirrhosis
* Patients have taken antibiotics within three months before screening for inclusion.
* Patients with a cardiac pacemaker or metallic implants,
* Patients are amputees
* Pregnant women
* Patients with inherited renal diseases
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Szu-Chun Hung
Attending physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SZU-CHUNG HUNG
Role: PRINCIPAL_INVESTIGATOR
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Tzu Chi Hospital
New Taipei City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Szu-Chun Hung, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-XD-074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.